Discussion in 'Stocks' started by nleeson, Dec 19, 2005.
You started the thread so what's the evidence?
i'm watching the level two there are prints .20 cent above the lowest offer.
something must be up
Great Christmas present if it is a weapon (doesn't sound like a cure)?
Look jonny, may i call you jonny. What you are obviously missing is that I am trying to give the stock a shameless plug because I am long out my ass...........and then you come in saying
"(doesn't sound like a cure)?"
Who the $**&%&* are you?
IT IS A CURE GODDAMMIT!
It's hard to say it's a cure and they don't even say that.
It modifys existing T-Cells, but the stem line will still produce T-Cells without the disrupted gene, thereby requiring continuous (and profitable) treatment. Unless it enables the body to completely clear the virus,you can't call it a cure.
But it sounds great, as it appears to have the potential to to allow the body to suppress the virus so that the individual is healthy and non-contagious.
This approach might lend itself toother therapies against other viruses, which, like the HIV, need a portal of entry into a human cell.
I wonder if this company can patent not just the new enzyme, but the whole works and sew up the general therapuetic approach.
Separate names with a comma.